ConductScience.org, home

Paper37166702

Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders.

Malar DS and 5 others. CNS Drugs, 2023. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders. Papers, record 37166702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37166702

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders.
PubMed
Journal
CNS Drugs
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
7.55
iCite
Revised in PubMed
2024-09-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Malar DSDicson Shttps://orcid.org/0000-0003-4253-9496
2Thitilertdecha PPremrutaihttps://orcid.org/0000-0002-1853-4073
3Ruckvongacheep KSKanokphorn Shttps://orcid.org/0009-0006-3656-2269
4Brimson SSirikalayahttps://orcid.org/0000-0003-3593-2601
5Tencomnao TTewinhttps://orcid.org/0000-0003-4177-2165
6Brimson JMJames Mhttps://orcid.org/0000-0003-2074-8262

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, sigmaMajor topic
Amyotrophic Lateral SclerosisMajor topic
Huntington DiseaseMajor topic
Neurodevelopmental DisordersMajor topic
Humans
Neurons

References417

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110066203Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.BMJ1999https://conductscience.org/library/papers/10066203PubMed
219370737Randomized controlled trial of memantine in dementia associated with Parkinson's disease.Mov Disord2009https://conductscience.org/library/papers/19370737PubMed
322935988Sigma-1R agonist improves motor function and motoneuron survival in ALS mice.Neurotherapeutics2012https://conductscience.org/library/papers/22935988PubMed
420071528Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.J Neurosci2010https://conductscience.org/library/papers/20071528PubMed
526595642Lewy body dementias.Lancet2015https://conductscience.org/library/papers/26595642PubMed
627926996Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease.J Neurochem2017https://conductscience.org/library/papers/27926996PubMed
729966437Sigma-2 receptor: past, present and perspectives on multiple therapeutic exploitations.Future Med Chem2018https://conductscience.org/library/papers/29966437PubMed
832318621
A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical study.
Alzheimers Dement (N Y)2020https://conductscience.org/library/papers/32318621PubMed
930832324Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo.Cells2019https://conductscience.org/library/papers/30832324PubMed
1015377746Fluvoxamine treatment of major depression associated with multiple sclerosis.J Neuropsychiatry Clin Neurosci2004https://conductscience.org/library/papers/15377746PubMed
116363736Landmark article Sept 17, 1938: Sodium diphenyl hydantoinate in the treatment of convulsive disorders. By H. Houston Merritt and Tracy J. Putnam.JAMA1984https://conductscience.org/library/papers/6363736PubMed
1225521311High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.Br J Pharmacol2015https://conductscience.org/library/papers/25521311PubMed
1334260979Effect of one-year dextromethorphan/quinidine treatment on management of respiratory impairment in amyotrophic lateral sclerosis.Respir Med2021https://conductscience.org/library/papers/34260979PubMed
1423922215Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy.Med Res Rev2014https://conductscience.org/library/papers/23922215PubMed
1532049741What are the epileptic encephalopathies?Curr Opin Neurol2020https://conductscience.org/library/papers/32049741PubMed
1621212100Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model.Hum Mol Genet2011https://conductscience.org/library/papers/21212100PubMed
1732284590Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.Nat Med2020https://conductscience.org/library/papers/32284590PubMed
1834445144An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies.Int J Mol Sci2021https://conductscience.org/library/papers/34445144PubMed
1923450660A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease.Mov Disord2013https://conductscience.org/library/papers/23450660PubMed
201717296Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.Eur J Pharmacol1991https://conductscience.org/library/papers/1717296PubMed

See all 417 referencesDownload CSV of references

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42985291Integrating multi-receptor and neuron-glia mechanisms of ketamine's antidepressant action: a convergence framework for understanding efficacy.Front Mol Neurosci2026https://conductscience.org/library/papers/42985291PubMed
42819592Blarcamesine improves EEG biomarkers of cortical dysfunction in a mouse model of fragile X syndrome.Front Pharmacol2026https://conductscience.org/library/papers/42819592PubMed
42769292A neuroprotective target in the shadows: a scoping review of pharmacological gaps in σ1R agonists for glutamate-induced neurotoxicity.Front Pharmacol2026https://conductscience.org/library/papers/42769292PubMed
42738830Sigma-1 Receptor Stimulation Rescues FTD/ALS Mutant TDP43-Induced Disruption of the VAPB-PTPIP51 ER-Mitochondria Tethering Proteins via Inhibition of GSK3β.Cells2026https://conductscience.org/library/papers/42738830PubMed
42560467Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer's Disease: A Systematic Review.CNS Drugs2026https://conductscience.org/library/papers/42560467PubMed
42313219Alzheimer's Disease and MERC Dysfunction: Integrating Mechanisms, Biomarkers, and Therapeutic Strategies.Mol Neurobiol2026https://conductscience.org/library/papers/42313219PubMed
42074241Cognitive Stimulation and Activity-Dependent Myelination: Oligodendroglial Mechanisms Linking Neural Activity and Brain Plasticity.Int J Mol Sci2026https://conductscience.org/library/papers/42074241PubMed
42074133Pridopidine Protects ALS Patient-Derived Neural Progenitor Cells via Sigma-1 Receptor Activation.Int J Mol Sci2026https://conductscience.org/library/papers/42074133PubMed
42039150Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer's disease therapy.Front Cell Dev Biol2026https://conductscience.org/library/papers/42039150PubMed
42022042SA4503 plays a protective role in post-resuscitation injury by reducing apoptosis caused by mitochondrial dysfunction and endoplasmic reticulum stress through the activation of sigma-1 receptor.Cytojournal2026https://conductscience.org/library/papers/42022042PubMed
41859358From metabolism to mood regulation: astrocytes as a driver of depression.Front Cell Neurosci2026https://conductscience.org/library/papers/41859358PubMed
41657419Current and emerging therapeutic strategies for amyotrophic lateral sclerosis: from pharmacological approaches to gene and stem cell therapies.Front Neurol2026https://conductscience.org/library/papers/41657419PubMed
41518900Dual sigma receptor 1 and 2 modulator improves memory behavior in mouse model of age-related cognitive decline.J Pharmacol Exp Ther2026https://conductscience.org/library/papers/41518900PubMed
41488323Sigma receptors and mitochondria-associated ER membranes are converging therapeutic targets for Alzheimer's disease.Front Neurosci2025https://conductscience.org/library/papers/41488323PubMed
41471389Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41471389PubMed
41269403Sigma-2 Receptor Antagonism Enhances the Neuroprotective Effects of Pridopidine, a Sigma-1 Receptor Agonist, in Huntington's Disease.Mol Neurobiol2025https://conductscience.org/library/papers/41269403PubMed
41020314Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management.Med Res Rev2026https://conductscience.org/library/papers/41020314PubMed
40965607Sigma-1 Receptor Ligands for CNS Cancer Treatment.CNS Drugs2025https://conductscience.org/library/papers/40965607PubMed
40957903Sustained antidepressant actions of ketamine involve TAMM41-mediated transfer of astrocytic sigma-1 receptor to neuron.Mol Psychiatry2026https://conductscience.org/library/papers/40957903PubMed
40956957Targeting the Milieu in Neurodegenerative Disease: Time for "Imprecision Medicine"?Aging Dis2025https://conductscience.org/library/papers/40956957PubMed

See all 40 cited byDownload CSV of cited by

Genes80

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACHE43PubTator's text mininghttps://conductscience.org/library/genes/43NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BDNF627PubTator's text mininghttps://conductscience.org/library/genes/627NCBI Gene
C9orf72203228PubTator's text mininghttps://conductscience.org/library/genes/203228NCBI Gene
CACNA1A773PubTator's text mininghttps://conductscience.org/library/genes/773NCBI Gene
CAV1857PubTator's text mininghttps://conductscience.org/library/genes/857NCBI Gene
CAV2858PubTator's text mininghttps://conductscience.org/library/genes/858NCBI Gene
CD521043PubTator's text mininghttps://conductscience.org/library/genes/1043NCBI Gene
CDKL56792PubTator's text mininghttps://conductscience.org/library/genes/6792NCBI Gene
CYBB1536PubTator's text mininghttps://conductscience.org/library/genes/1536NCBI Gene
CYCS54205PubTator's text mininghttps://conductscience.org/library/genes/54205NCBI Gene
CYP2D61565PubTator's text mininghttps://conductscience.org/library/genes/1565NCBI Gene
CYP46A110858PubTator's text mininghttps://conductscience.org/library/genes/10858NCBI Gene
ERLIN211160PubTator's text mininghttps://conductscience.org/library/genes/11160NCBI Gene
FLOT110211PubTator's text mininghttps://conductscience.org/library/genes/10211NCBI Gene
FUS2521PubTator's text mininghttps://conductscience.org/library/genes/2521NCBI Gene

See all 80 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37166702

GET https://conductscience.org/api/papers/v1/37166702/references?page=2